TCL Archive Sharp Increase In Cancer Mortality Could Bring Drastic Program Changes; All 1975 Data Needed December 12, 1975
TCL Archive After 30 Years As NCI-Designated Center, Vermont Cancer Center Loses Core Grant. November 14, 2008
TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013
TCL Archive Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said. February 18, 2005
